Somatostatin Receptor Imaging in Small Cell Lung Cancer

By Berenger N.   Moretti J.L.   Boaziz C.   Vigneron N.   Morere J.F.   Breau J.L.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1429-1431

Elsevier

Access to resources Recommend Favorite

Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr3-octreotide versusF-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy

By Virgolini I.   Patri P.   Novotny C.   Traub T.   Leimer M.   Füger B.   Li S.   Angelberger P.   Raderer M.   Wogritsch S.   Kurtaran A.   Kletter K.   Dudczak R.  

Annals of Oncology, Vol. 12, Iss. 2, 2001-02 ,pp. : 41-45

Springer Publishing Company

Access to resources Recommend Favorite

Increasing the Dose Intensity of Chemotherapy by Means of Granulocyte-colony Stimulating Factor (G-CSF) Support in the Treatment of Small Cell Lung Cancer (SCLC)

By Girling D.J.   Thatcher N.   Clark P.I.   Stephens R.J.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1263-1263

Elsevier

Access to resources Recommend Favorite

Combined Modality Treatment in Small Cell Lung Cancer (SCLC)

By Gregor A.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 816-818

Elsevier

Access to resources Recommend Favorite

A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice

By Kiaris H.   Schally A.V.   Nagy A.   Szepeshazi K.   Hebert F.   Halmos G.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 620-628

Elsevier

Access to resources Recommend Favorite